CAMZYOS®V (mavacamten)
bms logo
horizontal Rule

This website is intended for patients based in the UK who have been prescribed mavacamten▼

Please confirm if you are a member of the intended audience below

I confirm I am a patient based in the UK who has been prescribed mavacamten

I am not a patient based in the UK who has been prescribed mavacamten

horizontal Rule

3500-GB-2600077 | May 2026

References

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. By reporting side effects, you can help provide more information on the safety of this medicine.

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.yellowcard.mhra.gov.uk for how to report side effects. Side effects should also be reported to Bristol-Myers Squibb on 0800 731 1736 or medical.information@bms.com

 

Legal Notice    |    Privacy Policy    |    Cookie Preferences

© 2026 Bristol-Myers Squibb Company.